<div id="readability-page-1"><div><p>Certain A Shares of Huaxia Eye Hospital Group Co.,Ltd. are subject to a Lock-Up Agreement Ending on 7-NOV-2025. These A Shares will be under lockup for 1109 days starting from 25-OCT-2022 to 7-NOV-2025.</p><p>  Details:<br/> The Company?s actual controller Su Qingcan and person acting in concert Su Shihua committed: to not transfer or entrust to a third party the Company?s shares they hold directly or indirectly before the issuance, or allow the company to repurchase those shares within 36 months from the listing date. If within 6 months after the listing, the closing price of the shares is lower than the issuance price for 20 consecutive trading days or if the trading price is lower than the issuance price 6 months after listing, the lock-up period will be automatically extended for another 6 months. <br/> After the lock-up has expired, while holding office, they committed to not transfer more than 25% of shares held each year. </p><p>  The Company?s shareholder Huaxia Medical Investment (Xiamen) Co., Ltd. committed: to not transfer or entrust to a third party the Company?s shares they hold directly or indirectly before the issuance, or allow the company to repurchase those shares within 36 months from the listing date.</p><p>  The Company?s directors, supervisors, and senior management Chen Fengguo, Wang Qian, Huang Niya, Zhang Xiulian, Peng Jing, Li Xiaofeng, Zhang Hongtao, Chen Luyan, Cao Nai?en committed: to not transfer or entrust to a third party the Company?s shares they hold directly or indirectly before the issuance, or allow the company to repurchase those shares within 12 months from the listing date. If within 6 months after the listing, the closing price of the shares is lower than the issuance price for 20 consecutive trading days or if the trading price is lower than the issuance price 6 months after listing, the lock-up period will be automatically extended for another 6 months.</p><p>  After the lock-up has expired, while holding office, they committed to not transfer more than 25% of shares held each year.</p><p>The Company?s shareholders Xiamen Hanwei Equity Investment Partnership Enterprise (Limited Partnership), Panmao (Shanghai) Investment Center (Limited Partnership), Qilu (Xiamen) Equity Investment Partnership Enterprise (Limited Partnership), Xiamen Hongfu Equity Investment Partnership Enterprise (Limited Partnership), Xiamen Haoyun Equity Investment Partnership Enterprise (Limited Partnership), Xiamen Lukai Equity Investment Partnership Enterprise (Limited Partnership), Xiamen Bokai Equity Investment Partnership Enterprise (Limited Partnership), Xiamen Songsheng Equity Investment Partnership Enterprise (Limited Partnership), Shenzhen Qianhai Huaize Fangzhou Venture Capital Enterprise (Limited Partnership), Zhang Meichang, Li Xin committed: to not transfer or entrust to a third party the Company?s shares they hold directly or indirectly before the issuance, or allow the company to repurchase those shares within 12 months from the listing date.</p></div></div>

华厦眼科

<p>华厦眼科医院集团有限公司的部分 A 股在锁定协议下，直到 2025 年 11 月 7 日，锁定期为 1109 天，从 2022 年 10 月 25 日开始。包括实际控制人在内的关键利益相关者和各类股东已承诺在上市后的一定期限内不转让其股份。如果股价连续交易日低于发行价，锁定期可能会延长。锁定期结束后，他们每年只能转让 25% 的股份</p>

华厦眼科医院集团股份有限公司的部分 A 股受到锁定协议的限制，该协议将于2025年11月7日到期